New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...

(HealthDay News) — Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to a study ...

No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

(HealthDay News) — Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with Filipino Americans having the highest mortality ...

In solid organ transplant recipients (SOTRs) with advanced cancer treated with immune checkpoint inhibitors (ICIs), cancer outcomes and transplant rejection risk vary by cancer type, investigators ...

A phase 2 trial tested the efficacy and safety of potravitug, an investigational monoclonal antibody, in kidney transplant recipients with BK polyomavirus DNAemia.

The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary ...

(HealthDay News) — Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older ...

Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.

Using artificial intelligence tools in urology requires an open mind but with appropriate cautions according to clinicians ...